000153249 001__ 153249
000153249 005__ 20240229123043.0
000153249 0247_ $$2doi$$a10.1007/s12550-019-00384-6
000153249 0247_ $$2pmid$$apmid:31989413
000153249 0247_ $$2ISSN$$a0178-7888
000153249 0247_ $$2ISSN$$a1867-1632
000153249 0247_ $$2altmetric$$aaltmetric:74776773
000153249 037__ $$aDKFZ-2020-00282
000153249 041__ $$aeng
000153249 082__ $$a610
000153249 1001_ $$00000-0002-3811-9950$$aKyei, Nicholas N A$$b0
000153249 245__ $$aMaternal mycotoxin exposure and adverse pregnancy outcomes: a systematic review
000153249 260__ $$aHeidelberg$$bSpringer$$c2020
000153249 3367_ $$2DRIVER$$aarticle
000153249 3367_ $$2DataCite$$aOutput Types/Journal article
000153249 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1597744485_9638$$xReview Article
000153249 3367_ $$2BibTeX$$aARTICLE
000153249 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000153249 3367_ $$00$$2EndNote$$aJournal Article
000153249 500__ $$a2020 May;36(2):243-255
000153249 520__ $$aMycotoxin exposure from food occurs globally but is more common in hot humid environments, especially in low-income settings, and might affect pregnancy outcomes. This study aimed to synthesize the evidence from epidemiological studies on the relationship between maternal or fetal exposure to different mycotoxins and the occurrence of adverse pregnancy outcomes. Multiple databases were systematically searched up to December 2018 to identify studies that assessed the association between mycotoxin exposure in pregnant women or fetuses and at least one pregnancy outcome. Studies were appraised and results were synthesized using standard methods for conducting systematic reviews. This review identified and included 17 relevant studies. There is some evidence to suggest that exposure to various Aspergillus mycotoxins (e.g., aflatoxin) during pregnancy may impair intrauterine fetal growth and promote neonatal jaundice. Findings were inconclusive concerning the influence of aflatoxin exposure on perinatal death and preterm birth. Only two studies assessed effects of maternal exposure to Fusarium mycotoxins (e.g., fumonisin) on adverse pregnancy outcomes. These studies found that maternal fumonisin exposure may be associated with hypertensive emergencies in pregnancy and with neural tube defects. Studies using grain farming and weather conditions as a proxy measure for mycotoxin exposure found that such exposure was associated with an increased risk of preterm birth and late-term miscarriage. In conclusion, there is already some evidence to suggest that exposure to mycotoxins during pregnancy may have detrimental effects on pregnancy outcomes. However, given the limited number of studies, especially on effects of Fusarium mycotoxins, more studies are needed for a more comprehensive understanding of the effects of different mycotoxins on maternal and fetal health and to guide public health policies and interventions.
000153249 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000153249 588__ $$aDataset connected to CrossRef, PubMed,
000153249 7001_ $$0P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aBoakye, Daniel$$b1$$udkfz
000153249 7001_ $$aGabrysch, Sabine$$b2
000153249 773__ $$0PERI:(DE-600)2455358-X$$a10.1007/s12550-019-00384-6$$n2$$p243-255$$tMycotoxin research$$v36$$x1867-1632$$y2020
000153249 909CO $$ooai:inrepo02.dkfz.de:153249$$pVDB
000153249 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000153249 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000153249 9141_ $$y2020
000153249 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMYCOTOXIN RES : 2017
000153249 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000153249 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000153249 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000153249 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000153249 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000153249 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000153249 915__ $$0StatID:(DE-HGF)1060$$2StatID$$aDBCoverage$$bCurrent Contents - Agriculture, Biology and Environmental Sciences
000153249 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000153249 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000153249 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000153249 980__ $$ajournal
000153249 980__ $$aVDB
000153249 980__ $$aI:(DE-He78)C070-20160331
000153249 980__ $$aUNRESTRICTED